Skip to main content
Log in

Pharmacotherapy of ADHD in Slovenia: realities and perspectives

  • ESCAP Communication
  • Published:
European Child & Adolescent Psychiatry Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948

    Article  PubMed  Google Scholar 

  2. Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (2000) Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48:9–20

    Article  CAS  PubMed  Google Scholar 

  3. Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, Heal D, Müller U, Nash J, Santosh P, Sayal K, Sonuga-Barke E, Young SJ, British Association for Psychopharmacology (2014) Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol 28:179–203

    Article  PubMed  Google Scholar 

  4. NICE clinical guidelines CG72. Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. National Institute for Health and Care Excellence 2008. Available (November 2015), http://www.nice.org.uk/guidance/cg72

  5. Štuhec M, Švab V, Locatelli I (2015) Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective. Croat Med J 56:159–165

    Article  PubMed  PubMed Central  Google Scholar 

  6. Štuhec M, Locatelli I, Švab V (2015) Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in slovenia from 2001 to 2012: a drug use study from a national perspective. J Child Adolesc Psychopharmacol 25:254–259

  7. Schubert I, Köster I, Lehmkuhl G (2010) The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insures of the AOK Health Insurance Company in the German State of Hesse, 2000–2007. Dtsch Arztebl Int 107:615–621

  8. Štuhec M (2015) Hyperkinetic syndrome: from epidemiology to pharmacotherapy. Farmacevtskivestnik 66:177–184

    Google Scholar 

  9. Stuhec M, Munda B, Svab V, Locatelli I (2015) Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. J Affect Disord 178:149–159

    Article  CAS  PubMed  Google Scholar 

  10. Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P (2014) Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine. Curr Med Res Opin 30:1673–1685

    Article  CAS  PubMed  Google Scholar 

  11. Hervas A, Huss M, Johnson M, McNicholas F, van Stralen J, Sreckovic S, Lyne A, Bloomfield R, Sikirica V, Robertson B (2014) Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial. Euro Neuropsychopharmacol 12:1861–1872

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pharmacotherapy of ADHD in Slovenia: realities and perspectives. Eur Child Adolesc Psychiatry 25, 455–457 (2016). https://doi.org/10.1007/s00787-015-0811-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00787-015-0811-4

Navigation